Search - tctmd.com

Displaying 121 - 140 of 185

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

I'm Sure: Cangrelor Is Required In Addition!

Presenter: Gregg Stone

October 31, 2013

Presentation TCT 2013

EUROMAX: Critical Appraisal and Clinical Implications

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Presenter: Gregg Stone

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

Presentation TCT 2013

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Seminal Events in STEMI Reperfusion Therapy

Presenter: Gregg Stone

October 28, 2013

Presentation

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

Presenter: Gregg W. Stone

October 16, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Caitlin E. Cox

October 11, 2013

Presentation

Intralesional Abciximab and Thrombus Aspiration in Patients with Large Anterior MI: 1-Year Results of INFUSE-AMI

Presenter: Gregg W. Stone

October 04, 2013

News Daily News

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Yael L. Maxwell

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Presenter: Gregg W. Stone

March 07, 2013

Presentation TCT 2013

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Presenter: Joe Dizon, Sorin Brener, Akiko Maehara, Bernhard Witzenbichler, Jacek Godlewski, Helen Parise, Jan-Henk Dambrink, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Presenter: David Planer, E. Magnus Ohman, Harvey White, Jeffrey Moses, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Presenter: Magdi El-Omar, Sorin Brener, Akiko Maehara, Thomas Scott, Roxana Mehran, Wim Aengevaeren, Dariusz Dudek, Martin Fahy, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Presenter: Benoit Daneault, Philippe Genereux, Ajay Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Advertisement

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

I'm Sure: Cangrelor Is Required In Addition!

EUROMAX: Critical Appraisal and Clinical Implications

Primary PCI for STEMI: A Resounding Victory and Future Challenges

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Seminal Events in STEMI Reperfusion Therapy

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Intralesional Abciximab and Thrombus Aspiration in Patients with Large Anterior MI: 1-Year Results of INFUSE-AMI

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content